© 2021 MJH Life Sciences™ and Modern Retina. All rights reserved.
OT Staff Reports
Articles
FDA accepts Genentech's BLA for PDS with ranibizumab to treat wet AMD
June 25, 2021
Article
If approved, PDS ranibizumab would become the first and only eye implant with continuous drug delivery, offering an alternative to more frequent anti-VEGF injections for people with wet AMD.
Analysis of 24-month data from the PALADIN study
May 07, 2021
Video
Michael A. Singer, MD, speaks on the highlights of his presentation focusing on IOP in the PALADIN 24-month data intravitreal steroid (ILUVIEN).
A look at real-world trial data replication outcomes from IRIS Registry data
May 06, 2021
Video
Theodore Leng, MD, discusses the highlights from his presentation on "AAO IRIS Registry Data Replicates VIEW 1 and VIEW 2 Clinical Trial Outcome Data," during the virtual 2021 ARVO meeting.
Targeting neurodegenerative diseases with risuteganib as treatment therapy
May 03, 2021
Video
Glenn J. Jaffe, MD, discusses the key points of his virtual presentation on targeting neurodegenerative diseases with risuteganib, minimizing damage to the retina when compromised, and the need for newer treatment therapies to target different pathways.